NCH 51

Discontinued Product

3747 has been discontinued.

View all Non-selective HDACs products.
说明: Histone deacetylase inhibitor
别名: PTACH
化学名: 2-Methylpropanethioic acid S-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl] ester
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for NCH 51

NCH 51 is a histone deacetylase (HDAC) inhibitor. Inhibits growth of various cancer cells in vitro (EC50 = 1.1 - 9.1 μM).

技术数据 for NCH 51

分子量 390.56
公式 C20H26N2O2S2
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 848354-66-5
PubChem ID 11395181
InChI Key MDYDGUOQFUQOGE-UHFFFAOYSA-N
Smiles O=C(CCCCCCSC(C(C)C)=O)NC1=NC(C2=CC=CC=C2)=CS1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for NCH 51

分析证书/产品说明书
选择另一批次:

关键词: NCH 51, NCH 51 supplier, NCH51, HDACs, inhibitors, inhibits, histone, deacetylases, epigenetics, PTACH, Non-selective, Non-Selective, 3747, Tocris Bioscience

篇 NCH 51 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 NCH 51 的引用文献。

NCH 51 的评论

目前没有该产品的评论。 Be the first to review NCH 51 and earn rewards!

Have you used NCH 51?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Epigenetics Scientific Review

Epigenetics Scientific Review

Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.

Rheumatoid Arthritis Poster

Rheumatoid Arthritis Poster

Rheumatoid arthritis (RA) is a chronic destructive inflammatory autoimmune disease that results from a breakdown in immune tolerance, for reasons that are as yet unknown. This poster summarizes the pathology of RA and the inflammatory processes involved, as well as describing some of the epigenetic modifications associated with the disease and the potential for targeting these changes in the discovery of new treatments.